Abstract:
A method of manufacturing a vaccine composition containing antigen extracted from pig tissue infected with a complex respiratory disease is provided to prevent and treat a post weaning multisystemic wasting syndrome(PMWS) and a pig respiratory organ complex syndrome(PRDC). A method of manufacture the vaccine composition comprises steps of: i) removing pig tissue infected with a complex respiratory diseases; ii) extracting antigen by adding a solution comprising a glycine buffer solution and triton X-100 of 0.5% to the tissue; and iii) being inactivated by a formalin.
Abstract:
본 발명은 항원-항체 반응을 이용하여 신속하게 돼지콜레라바이러스에 대한 항체의 존재유무를 검출할 수 있도록 고안된 검출 키트 및 이를 이용한 돼지콜레라바이러스 항체의 검출 방법에 관한 것이다. 돼지콜레라, 면역크로마토그라피, 골드 콘쥬게이트, 유전자 재조합
Abstract:
PURPOSE: An attenuated vaccine prepared by isolating a Theileria sergenti Sungwhan stock from Haemaphysalis longicornis and then attenuating it is provided. The vaccine has recognizable specific protection property and thus can be effectively used in the prevention of bovine theileriosis. CONSTITUTION: An attenuated vaccine is prepared by the steps of: recovering Haemaphysalis longicornis imagoes from bovines infected with theileriosis; infecting a rabbit with the Haemaphysalis longicornis imagoes for 6 to 7 days; and aseptically collecting salivary gland from the collected Haemaphysalis longicornis imagoes. The vaccine is formed into an injectable formulation.
Abstract:
본발명은 T 세포의병원체감염세포증식억제능평가방법및 세포억제능에관여하는병원체특이적 T 세포의정보제공방법에관한것이다. 본발명의 T 세포의병원체감염세포증식억제능평가방법은직접적으로돼지를이용하지않고도실험실내 in vitro 상에서평가가능하고, 또한, T 세포가추출된세포의개체와동일개체(autologous) 혹은동일유전자형을가진다른개체(heterologous)에대한 PRRSV 증식억제를확인할수 있는효과가있어, 백신및 면역증강제의효능평가분야에유용하게이용할수 있다.
Abstract:
The present invention relates to a bio probe for detecting swine fever virus, comprising (a) a nanomaterial; (b) an antibody which is specifically combined with an antigen of swine fever virus covalently linked to the surface of the nanomaterial; and (c) a glass fiber, as a solid substrate, having a surface which is modified by the antibody combined nanomaterial. The present invention also relates to a method for diagnosing swine fever virus using the bio probe. According to the present invention, the existence and infection of swine fever virus can be rapidly checked within 10 minutes using a small amount of a sample.
Abstract:
PURPOSE: A recombinant baculovirus is provided to protect a swinery from novel swine-origin influenza A(H1N1) and to prevent new or variant virus expressed in a pig. CONSTITUTION: A recombinant baculovirus is prepared by inserting a gene which expresses HA(hemagglutinin), a gene which expresses NA(neuraminidase), and a gene which expresses M1(matrix 1) protein. The HA expressing gene is a gene(GeneBank FJ966082) which expresses HA of influenza virus A/California/04/2009(CA09). The NA expressing gene is a gene(GeneBank FJ966084) which expresses NA of influenzavirus A/California/04/2009(CA09). The M1 protein expressing gene is a gene(GeneBank FJ969513) which expresses M1 protein of influenza virus A/California/04/2009(CA09). A VLP(Virus-Like Particle) for suppressing swine influenza viral infection contains the recombinant baculovirus. A vaccine for suppressing swine influenza viral infection contains the VLP. [Reference numerals] (AA) Tn7L,Tn7R sequence homologous recombination for Baculovirus
Abstract translation:目的:提供重组杆状病毒以保护猪只免受猪源甲型H1N1流感病毒侵袭,并防止在猪中表达的新病毒或变异病毒。 构成:通过插入表达HA(血凝素)的基因,表达NA(神经氨酸酶)的基因和表达M1(基质1)蛋白质的基因来制备重组杆状病毒。 HA表达基因是表达流感病毒A / California / 04/2009(CA09)的HA的基因(GeneBank FJ966082)。 NA表达基因是表达流感病毒A / California / 04/2009(CA09)的NA的基因(GeneBank FJ966084)。 M1蛋白表达基因是表达流感病毒A / California / 04/2009(CA09)的M1蛋白的基因(GeneBank FJ969513)。 用于抑制猪流感病毒感染的VLP(病毒样颗粒)含有重组杆状病毒。 用于抑制猪流感病毒感染的疫苗包含VLP。 (AA)Tn7L,Tn7R序列同源重组杆状病毒
Abstract:
PURPOSE: A solid particle having end epoxy radical on lipid bilayer and a manufacturing method thereof are provided to uniformly fix molecules having amino radicals under mild condition. CONSTITUTION: A solid particle having end epoxy radical includes lipid bilayer coated with polyelectrolyte material on a surface. The lipid bilayer comprises a first lipid molecule and a second lipid molecule. The first lipid molecule is diacetylene having the first lipid molecule having epoxy radical in the end. The second lipid molecule is a different lipid molecule from the first lipid molecule. A solid particle before being coated with the polyelectrolyte material is negative charged material. A cationic polyelectrolyte material and electronegative polyelectrolyte material are coated by turns.
Abstract:
An antiviral agent is provided to exhibit advantageous effects of selectively degrading foreign nucleic acid chains invaded in an animal cell and have no cytotoxicity to the animal cell, thereby causing no death of the animal cell. An anti-viral agent against animal viruses comprises: a protein which has the binding capacity and the decomposing capacity regarding a foreign nucleic acid chain invading animal cells and shows no toxicity on the animal cells; or a nucleic acid encoding the same protein as an effective ingredient, wherein the protein is recovered from an auto-immune disease induced animal and is an immunoglobulin or a fragment thereof having the binding capacity and the decomposing capacity regarding the nucleic acid chain. Further, the immunoglobulin is an immunoglobulin G.
Abstract:
본 발명은 돼지콜레라 바이러스 E rns 단백질 및 이에 특이적으로 반응하는 단클론항체를 이용한 돼지콜레라 항체 감별 진단방법에 관한 것으로, 더욱 상세하게는 국내에서 분리된 다양한 유전형의 돼지콜레라 바이러스(swine fever virus) 중 3종의 E rns 단백질을 코딩하는 유전자를 배큘로바이러스(Baculovirus)를 이용하여 발현한 재조합 돼지콜레라 바이러스 E rns 단백질, 및 상기 E rns 단백질에 특이적으로 반응하는 단클론항체(monoclonal antibody)를 이용하여 돼지콜레라 E rns 에 대한 항체를 검사하는 방법에 관한 것이다. 본 발명의 단클론항체를 이용하는 경우에 E rns 에 대한 항체를 검출할 수 있어 야외에서 감염된 돼지콜레라 바이러스 항체를 용이하게 감별 진단할 수 있으며, 또한 본 발명의 진단 방법은, 3종의 재조합 단백질을 동시에 이용하는 경우에 돼지콜레라 바이러스의 모든 유전형에 대해 유전형에 관계없이 일정한 민감도를 나타내므로, 돼지콜레라 바이러스에 대한 항체를 용이하게 검출할 수 있다. 돼지 콜레라 바이러스, 이알엔에스, 단클론항체, 감별 ELISA
Abstract:
A method for screening and detecting a swine fever virus antibody is provided to easily screen and diagnose infected swine fever virus antibody by using a monoclonal antibody specifically reacting with a recombinant swine fever virus Erns protein and secure constant sensitivity regardless of all genotypes of the swine fever virus when using all three kinds of recombinant protein. A recombinant swine fever virus Erns is prepared by expressing a gene encoding three Erns proteins among swine fever viruses having various genotypes using baculovirus. A method for preparing a monoclonal antibody specifically reacting to the Erns comprises the steps of: (a) constructing a swine fever virus LOM strain-derived Erns recombinant gene using a baculovirus expression system; and (b) producing the monoclonal antibody using the recombinant Erns protein. A method for screening and detecting a swine fever virus antibody comprises the steps of: (a) mixing three kinds of Erns recombinant proteins at proper concentration to prepare an antigen cocktail; (b) after diluting the antigen cocktail into a coating buffer solution, pouring it in a plate to be absorbed into the plate; (c) washing the recombinant antigen not-absorbed into the plate to remove it; (d) adding a sample to be tested to the plat to allow the reaction; (e) washing the sample to be tested not specifically bound to the recombinant Erns antigen protein absorbed into the plate to remove it; (f) adding a monoclonal antibody not being bound to the enzyme but being specifically reacted to the Erns protein to allow the reaction; (g) washing the monoclonal antibody not being bound to the recombinant Erns antigen protein absorbed into the plate to remove it; and (h) adding a substrate reacting with the enzyme to determine the swine fever virus infection.